» Articles » PMID: 19838195

A Large-scale Replication Study Identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 As Risk Loci for Systemic Lupus Erythematosus

Abstract

Genome-wide association studies have recently identified at least 15 susceptibility loci for systemic lupus erythematosus (SLE). To confirm additional risk loci, we selected SNPs from 2,466 regions that showed nominal evidence of association to SLE (P < 0.05) in a genome-wide study and genotyped them in an independent sample of 1,963 cases and 4,329 controls. This replication effort identified five new SLE susceptibility loci (P < 5 x 10(-8)): TNIP1 (odds ratio (OR) = 1.27), PRDM1 (OR = 1.20), JAZF1 (OR = 1.20), UHRF1BP1 (OR = 1.17) and IL10 (OR = 1.19). We identified 21 additional candidate loci with P< or = 1 x 10(-5). A candidate screen of alleles previously associated with other autoimmune diseases suggested five loci (P < 1 x 10(-3)) that may contribute to SLE: IFIH1, CFB, CLEC16A, IL12B and SH2B3. These results expand the number of confirmed and candidate SLE susceptibility loci and implicate several key immunologic pathways in SLE pathogenesis.

Citing Articles

Exploring the shared mechanism of fatigue between systemic lupus erythematosus and myalgic encephalomyelitis/chronic fatigue syndrome: monocytic dysregulation and drug repurposing.

Zheng D, Li X, Wang P, Zhu Q, Huang Z, Zhao T Front Immunol. 2025; 15():1440922.

PMID: 39845969 PMC: 11752880. DOI: 10.3389/fimmu.2024.1440922.


From early methods for DNA diagnostics to genomes and epigenomes at high resolution during four decades - a personal perspective.

Syvanen A Ups J Med Sci. 2024; 129.

PMID: 39691779 PMC: 11650520. DOI: 10.48101/ujms.v129.11134.


Genome-wide meta-analysis of myasthenia gravis uncovers new loci and provides insights into polygenic prediction.

Braun A, Shekhar S, Levey D, Straub P, Kraft J, Panagiotaropoulou G Nat Commun. 2024; 15(1):9839.

PMID: 39537604 PMC: 11560923. DOI: 10.1038/s41467-024-53595-6.


Association of hyperactivated transposon expression with exacerbated immune activation in systemic lupus erythematosus.

Wang F, Dang X, Su H, Lei Y, She C, Zhang C Mob DNA. 2024; 15(1):23.

PMID: 39427224 PMC: 11490001. DOI: 10.1186/s13100-024-00335-8.


BLTP3A is associated with membranes of the late endocytic pathway and is an effector of CASM.

Hanna M, Rodriguez Cruz H, Fujise K, Wu Y, Xu C, Pang S bioRxiv. 2024; .

PMID: 39386594 PMC: 11463362. DOI: 10.1101/2024.09.28.615015.


References
1.
Sawalha A, Webb R, Han S, Kelly J, Kaufman K, Kimberly R . Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS One. 2008; 3(3):e1727. PMC: 2253825. DOI: 10.1371/journal.pone.0001727. View

2.
Arita K, Ariyoshi M, Tochio H, Nakamura Y, Shirakawa M . Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. Nature. 2008; 455(7214):818-21. DOI: 10.1038/nature07249. View

3.
Nair R, Callis Duffin K, Helms C, Ding J, Stuart P, Goldgar D . Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009; 41(2):199-204. PMC: 2745122. DOI: 10.1038/ng.311. View

4.
Zeggini E, Scott L, Saxena R, Voight B, Marchini J, Hu T . Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008; 40(5):638-45. PMC: 2672416. DOI: 10.1038/ng.120. View

5.
Jacob C, Zhu J, Armstrong D, Yan M, Han J, Zhou X . Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A. 2009; 106(15):6256-61. PMC: 2669395. DOI: 10.1073/pnas.0901181106. View